» Articles » PMID: 31440387

Enhancement of Mesenchymal Stem Cell-Driven Bone Regeneration by Resveratrol-Mediated SOX2 Regulation

Overview
Journal Aging Dis
Specialty Geriatrics
Date 2019 Aug 24
PMID 31440387
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Mesenchymal stem cells (MSCs) are an attractive cell source for regenerative medicine. However, MSCs age rapidly during long-term culture and lose their therapeutic potential before they reach effective cell doses (ECD) for cell therapy. Thus, a prerequisite for effective MSC therapy is the development of cell culture methods to preserve the therapeutic potential during long-term cultivation. Resveratrol (RSV) has been highlighted as a therapeutic candidate for bone disease. Although RSV treatment has beneficial effects on bone-forming cells, studies are lacking. The current study showed that long-term (6 weeks from primary culture date)-cultured MSCs with RSV induction retained their proliferative and differentiation potential despite reaching ECD. The mechanism of RSV action depends entirely on the SIRT1-SOX2 axis in MSC culture. In a rat calvarial defect model, RSV induction significantly improved bone regeneration after MSC transplantation. This study demonstrated an example of efficient MSC therapy for treating bone defects by providing a new strategy using the plant polyphenol RSV.

Citing Articles

Mesenchymal Stromal Cells for Aging Cartilage Regeneration: A Review.

Wu K, Chang Y, Ding D, Lin S Int J Mol Sci. 2024; 25(23.

PMID: 39684619 PMC: 11641625. DOI: 10.3390/ijms252312911.


The Role of Mitochondrial Homeostasis in Mesenchymal Stem Cell Therapy-Potential Implications in the Treatment of Osteogenesis Imperfecta.

Guo Q, Zhai Q, Ji P Pharmaceuticals (Basel). 2024; 17(10).

PMID: 39458939 PMC: 11510265. DOI: 10.3390/ph17101297.


Phytochemical Compounds Involved in the Bone Regeneration Process and Their Innovative Administration: A Systematic Review.

Hanga-Farcas A, Miere Groza F, Filip G, Clichici S, Fritea L, Vicas L Plants (Basel). 2023; 12(10).

PMID: 37653972 PMC: 10222459. DOI: 10.3390/plants12102055.


Recent advances on small molecules in osteogenic differentiation of stem cells and the underlying signaling pathways.

Ahmadi A, Mazloomnejad R, Kasravi M, Gholamine B, Bahrami S, Sarzaeem M Stem Cell Res Ther. 2022; 13(1):518.

PMID: 36371202 PMC: 9652959. DOI: 10.1186/s13287-022-03204-4.


Role of quercetin and rutin in enhancing the therapeutic potential of mesenchymal stem cells for cold induced burn wound.

Irfan F, Jameel F, Khan I, Aslam R, Faizi S, Salim A Regen Ther. 2022; 21:225-238.

PMID: 36092499 PMC: 9420879. DOI: 10.1016/j.reth.2022.07.011.


References
1.
Pittenger M, Mackay A, Beck S, Jaiswal R, Douglas R, Mosca J . Multilineage potential of adult human mesenchymal stem cells. Science. 1999; 284(5411):143-7. DOI: 10.1126/science.284.5411.143. View

2.
Rombouts W, Ploemacher R . Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture. Leukemia. 2003; 17(1):160-70. DOI: 10.1038/sj.leu.2402763. View

3.
Le Blanc K, Tammik L, Sundberg B, Haynesworth S, Ringden O . Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol. 2003; 57(1):11-20. DOI: 10.1046/j.1365-3083.2003.01176.x. View

4.
Komori T . Requisite roles of Runx2 and Cbfb in skeletal development. J Bone Miner Metab. 2003; 21(4):193-7. DOI: 10.1007/s00774-002-0408-0. View

5.
Howitz K, Bitterman K, Cohen H, Lamming D, Lavu S, Wood J . Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature. 2003; 425(6954):191-6. DOI: 10.1038/nature01960. View